Proposed model of phosphodiesterase (PDE) and protein kinase (PK)... | Download Scientific Diagram
Pivotal effects of phosphodiesterase inhibitors on myocyte contractility and viability in normal and ischemic hearts | Acta Pharmacologica Sinica
Different phosphodiesterases (PDEs) regulate distinct phosphoproteomes during cAMP signaling | PNAS
IJMS | Free Full-Text | Phosphodiesterase Inhibitors: Could They Be Beneficial for the Treatment of COVID-19?
PDE-Glo™ Phosphodiesterase Assay
Frontiers | The cAMP Pathway as Therapeutic Target in Autoimmune and Inflammatory Diseases
IJMS | Free Full-Text | Therapeutic Implications for PDE2 and cGMP/cAMP Mediated Crosstalk in Cardiovascular Diseases | HTML
Phosphodiesterase | PDE3
Concerted Regulation of cGMP and cAMP Phosphodiesterases in Early Cardiac Hypertrophy Induced by Angiotensin II | PLOS ONE
Resveratrol Ameliorates Aging-Related Metabolic Phenotypes by Inhibiting cAMP Phosphodiesterases: Cell
Overview of PDEs and Their Regulation | Circulation Research
Phosphodiesterases in endocrine physiology and disease in: European Journal of Endocrinology Volume 165 Issue 2 (2011)
Phosphodiesterase 3 - Wikipedia
Phosphodiesterases Catalyze Hydrolysis of cAMP-bound to Regulatory Subunit of Protein Kinase A and Mediate Signal Termination* - Molecular & Cellular Proteomics
CV Pharmacology | Phosphodiesterase Inhibitors
Frontiers | Phosphodiesterases and cAMP Pathway in Pituitary Diseases
Cell based PDE assays for Compoud Screening | eEnzyme
PDEs as drug targets – Mironid
Complex roles of cAMP–PKA–CREB signaling in cancer | Experimental Hematology & Oncology | Full Text
Role of phosphodiesterases in the pathophysiology of neurodevelopmental disorders | Molecular Psychiatry
Phosphodiesterases as therapeutic targets for respiratory diseases - ScienceDirect
Phosphodiesterase 9A (PDE9)/cGMP ACTOne Cell Line (CB-81300-101), 1 vial CDXC30011
Channeling of cAMP in PDE-PKA Complexes Promotes Signal Adaptation
Phosphodiesterase - Wikipedia
Dart NeuroScience LLC -- Internal Research -- Memory Enhancers
Cyclic Nucleotide Phosphodiesterases: Molecular Regulation to Clinical Use | Pharmacological Reviews